Latest Institutional Purchases of Vigil Neuroscience, Inc. (VIGL)
This list provides information on the latest institutional transactions involving Vigil Neuroscience, Inc. (VIGL) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 10, 2023
Q2 2023
|
Metropolitan Life Insurance CO
New York, NY |
BUY
|
- |
944New |
$7.66K - $9.95K
|
944
$2.04K
|
|
|
Aug 14, 2023
Q2 2023
|
State Of Wyoming
Cheyenne, WY |
BUY
|
- |
42+ 41.58% |
$341 - $443
|
143
$309
|
|
| Q1 2023 | |||||||
|
May 15, 2023
Q1 2023
|
Man Group PLC
London, X0 |
BUY
|
- |
11.7KNew |
$103K - $149K
|
11.7K
$25.3K
|
|
|
Jun 13, 2024
Q1 2023
|
Bank Of Montreal
Toronto, A6 |
BUY
|
- |
7.93K+ 23.75% |
$69.5K - $101K
|
41.3K
$89.2K
|
|
|
May 10, 2023
Q1 2023
|
Coppell Advisory Solutions Corp.
Coppell, TX |
BUY
|
- |
3K+ 999.33% |
$26.3K - $38.1K
|
3.3K
$7.12K
|
|
| Q4 2022 | |||||||
|
Feb 14, 2023
Q4 2022
|
Trustees Of Columbia University In The City Of New York
New York, NY |
BUY
|
- |
193KNew |
$1.69M - $3.09M
|
193K
$417K
|
|
|
Feb 14, 2023
Q4 2022
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
- |
37.7K+ 9.17% |
$329K - $603K
|
449K
$970K
|
|
| Q3 2022 | |||||||
|
Nov 14, 2022
Q3 2022
|
Bvf Inc
San Francisco, CA |
BUY
|
- |
1.81MNew |
$4.3M - $17.4M
|
1.81M
$3.92M
|
|
|
Nov 14, 2022
Q3 2022
|
Ergoteles LLC
New York, NY |
BUY
|
- |
28.5KNew |
$67.6K - $274K
|
28.5K
$61.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Altium Capital Management LP
New York, NY |
BUY
|
- |
15.8KNew |
$37.4K - $152K
|
15.8K
$34.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Cannell Capital LLC
Alta, WY |
BUY
|
- |
4.41K+ 121.23% |
$10.4K - $42.4K
|
8.04K
$17.4K
|
|
| Q2 2022 | |||||||
|
Aug 15, 2022
Q2 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
BUY
|
- |
22.3KNew |
$49.7K - $174K
|
22.3K
$48.1K
|
|
|
Aug 12, 2022
Q2 2022
|
Credit Suisse Ag
Zurich, V8 |
BUY
|
- |
4New |
$8.92 - $31.2
|
4
$8.64
|
|
| Q1 2022 | |||||||
|
May 16, 2022
Q1 2022
|
Atlas Venture Life Science Advisors, LLC
|
BUY
|
- |
5.84MNew |
$41M - $101M
|
5.84M
$12.6M
|
|
|
May 16, 2022
Q1 2022
|
Northpond Ventures, LLC
|
BUY
|
- |
4.21MNew |
$29.6M - $72.9M
|
4.21M
$9.1M
|
|
|
May 16, 2022
Q1 2022
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
617KNew |
$4.34M - $10.7M
|
617K
$1.33M
|
|
|
May 13, 2022
Q1 2022
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
BUY
|
- |
561KNew |
$3.94M - $9.69M
|
561K
$1.21M
|
|
|
May 16, 2022
Q1 2022
|
Rock Springs Capital Management LP
Baltimore, MD |
BUY
|
- |
472KNew |
$3.32M - $8.16M
|
472K
$1.02M
|
|
|
May 13, 2022
Q1 2022
|
Harvard Management CO Inc
Boston, MA |
BUY
|
- |
289KNew |
$2.03M - $5M
|
289K
$625K
|
|
|
May 16, 2022
Q1 2022
|
Davidson Kempner Capital Management LP
New York, NY |
BUY
|
- |
30KNew |
$211K - $519K
|
30K
$64.8K
|
|